Caliper Life Sciences is a prominent company in the biotechnology and pharmaceutical industries, offering innovative products, services, and systems to academic, government, and biotech/pharmaceutical researchers globally. Established in 1995 and based in Hopkinton, Massachusetts, Caliper, a PerkinElmer Company, specializes in molecular solutions for preclinical imaging, in vitro research, and diagnostics. Its diverse portfolio of microfluidics, automation, liquid handling, and molecular imaging technologies addresses various pre-clinical drug discovery and development bottlenecks. The company's product range includes LabChip drug discovery, profiling and separations systems; IVIS noninvasive imaging systems, reagents, and animal models; and automation and liquid handling systems. Caliper also provides contract research, transgenic animal services, drug discovery and development services, product support, and validation services. Moreover, the company secured a Seed Round investment on 01 January 1996 from Venrock. Caliper Life Sciences serves its customers directly and through a network of distributors, catering to the evolving needs of the research and pharmaceutical sectors. With its comprehensive offerings and industry expertise, Caliper continues to make significant contributions to the advancement of preclinical drug discovery and development.
No recent news or press coverage available for Caliper Life Sciences.